Association of CTNNB1 and APC mutation status with treatment outcome in patients with desmoid-type fibromatosis

Association of CTNNB1 and APC mutation status with treatment outcome in patients with desmoid-type fibromatosis - CTNNB1 mutation analysis in desmoid tumor

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020550

Enrollment

100

Registered

2016-01-14

Start date

2015-04-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

desmoid-type fibromatosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: histological determination as desmoid-type fibromatosis

Exclusion criteria

Exclusion criteria: informed consent not obtained

Design outcomes

Primary

Measure	Time frame
Identify mutation type of CTNNB1, evaluate relationship between mutation type of CTNNB1 and treatment outcome in patients with desmoid-type fibromatosis	—

Countries

Japan

Contacts

Public ContactTomohisa Sakai

Nagoya University Hospital Orthopaedic Surgery

tosakai@med.nagoya-u.ac.jp052-741-2111

Outcome results